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INTRODUCTION
I
INTRODUCTION
           Spontaneous rupture of membranes usually coincides with labour. When it 
precedes onset of labour by a latent interval varying from hours to days and weeks it is 
termed as premature rupture of membranes (PROM) or, more aptly prelabour rupture of 
membranes. If it occurs at any time prior to 37 completed weeks of gestation, it is titled 
preterm premature rupture of membranes (PPROM).
           The incidence of PPROM is 3% of all pregnancies and it is responsible for 40% 
of  all  preterm deliveries  (Parrys  S  et  al).  The  time  interval  between  the  rupture  of 
membranes and onset of labour (latent period) may extend from hours to days. Generally 
shorter the gestational period, the longer the latent period. In case of PPROM, labour 
generally  sets  in  within  24  hrs  in  25-50%  and  within  72hrs  in  70%  patient.  The 
incidence of PPROM varies from
                          0.5% before 26weeks
                          1.0% between 26 and 34 weeks
                          1.5% between 34 and 37 weeks
            The incidence of RDS is estimated to decrease from 15% at 34weeks to below 
1% at 37 weeks (Lewis et al).  On the other hand the probability that sepsis occurs, 
increases when expectant management is advocated. In 
case, the child born immediately after PROM, the risk of sepsis is  2.5%, whereas it 
increases to 7.5% in case of expectant management (Lieman et al). Preterm PROM is a 
greater affront to the mother and her fetus compared to term PROM, considering the 
problems of maternal infection and fetal prematurity. 
             The most favourable approach in dealing with preterm premature rupture of 
membranes at 34 weeks 0 days to 36 weeks 6 days remains controversial. Recent studies 
suggest that prolonging gestation beyond 34 weeks results in low or no reduction in 
mortality. Alternatively, it has been suggested that induction of labour after rupture of 
membranes,  particularly  in  gravid  women  with  an  unfavourable  cervix  may  be 
associated with increased rate of cesarean delivery. 
             Therefore the obstetrician has to strike a fine balance between conservative 
approach and induction of labour and the management choice has to be individualized 
after a complete clinical appraisal. This prospective study is undertaken to investigate 
difference in maternal and neonatal morbidity associated with active versus expectant 
management of PPROM at 34 to 37 weeks of gestation.      
REVIEW OF
         LITERATURE
 REVIEW OF LITERATURE
DEFINITION
         Preterm rupture of membranes is defined as rupture of fetal membranes occurring 
prior to the onset of labour. Preterm premature rupture of membranes (PPROM) refers to 
the occurrence of this event prior to 37 weeks of gestation.
INCIDENCE
          The incidence of PPROM varies from
                          0.5% before 26weeks
                          1.0% between 26 and 34 weeks
                          1.5% between 34 and 37 weeks
            It accounts for about one fourth of all cases of ruptured membranes. PPROM is 
responsible for close to 40% of preterm births (Parrys S et al).
SIGNIFICANCE
           PPROM is associated with significant  maternal complications, increase in 
operative intervention and neonatal  morbidity and mortality.  Because PPROM is the 
leading  cause  of  preterm  birth  and  perinatal  morbidity,  it  has  a  tremendous  socio-
economic impact in the society.
PATHOPHYSIOLOGY
         PPROM is a complex and multifactorial entity. The fetal membranes are composed 
of the amnion and chorion bound together by different layers composed of extracellular 
matrix.  This  matrix  is  the  key  factor  for  the  elasticity  and  tensile  strength  of  fetal 
membranes. The tensile strength guarantees the role of the membranes as a physical and 
functional boundary for the fetus during pregnancy (Vadillo-Ontego et al).  If the extra 
cellular  matrix is  intact,  the fetal  membrane’s  elasticity  and tensile strength is  at  its 
maximum;  hence  any  process  that  weakens  the  matrix  metalloproteinases  (MMPs) 
increases the risk of PPROM.
Risk factors are
      Previous pregnancy with PPROM (21%)
      Antepartum haemorrhage 
      Multiple gestation
      Polyhydramnios (excessive membrane distension)
      Smoking
      Illicit drugs such as heroin and cocaine
      Cervical insufficiency
      Infection
 
      Prenatal diagnostic procedures like chorionic villus sampling and amniocentesis
       Mineral & Vitamin deficiencies
       Digital examination       
       Positive fibrinonectin
       Prior cervical surgical procedures
       Ehlers –Danlos syndrome.
       Placental pathology  
          Greatest risk factor for PPROM is infection. It has been demonstrated that 
bacterial proteases decreases the strength and elasticity of chorioamniotic membranes 
(McGregor JA et al). Women who are infected with Gonorrhea (Edwards LE, Barrada 
MI, Hammam AE et al), Trichomonas, or Chlamydia (Martin et al), and those infected 
with Group B  hemolytic streptococcus (Regan et al) or Gardenella vaginalis also have 
an increased risk of PPROM(Minkoff et al). Bacteria which colonize the genital tract 
have  the  capability  of  producing  phospholipases  which  stimulate  the  release  of 
prostaglandins from the breakdown of arachidonic acid, leading to preterm contractions. 
Infection also causes a host immune response, releasing pro-inflammatory cytokines and 
mediators which cause weakening 
of the fetal membranes by disrupting its extracellular matrix and releasing MMPs.
          MMPs are a family of enzymes with varied substrate specificities that decrease 
membrane strength by increasing collagen degradation. The activation of MMP-9, a 92-
kDa  type  IV  collagenase,  as  an  essential  mediator  of  tissue  damage  is  under 
investigation.
           The  local  physiological  signal  by amniochorion cells  to  induce MMP-9 
expression is not known, but bacterial products and/or the pro inflammatory cytokines, 
IL-1 β and TNF- α,  as paracrine or autocrine signals may trigger these processes  in 
pregnancies complicated with intra amniotic infections (VallidoOrtego et al). In 2003, 
Romero et al described MMP-3 as a physiological constituent of amniotic fluid that may 
play a role in the mechanism of human parturition and in the regulation of host response 
to intrauterine infection. Microbial invasion of amniotic cavity in preterm gestation has 
also  been  associated  with  a  significant  increase  in  amniotic  fluid  concentration  of 
MMP-7, playing a role in host defense mechanism. (Maymon E, Romero R, Pacona P et 
al). Marked elevations of mid trimester amniotic fluid MMP-8 have also been found to 
be associated with subsequent preterm premature rupture of membranes, suggesting that 
pathophysiological processes that contribute to preterm premature rupture of membranes 
may begin early in pregnancy (Biggio Jr JR et al).
              Genetic susceptibility may be a risk factor for PPROM. In 2002, the MMP-9 
gene  promoter  activity  and  its  association  with  PPROM  were  described.  It  was 
concluded that there are cell host-dependent differences in MMP-9 promoter activity. In 
African- American neonates born from pregnancies complicated with PPROM, the allele 
associated with the increase in the MMP-9 promoter activity expression was found to be 
present, compared to those neonates who delivered at term without PPROM (Ferrand 
PE,  Parry  S,  Sammel  M  et  al).African-American  females  who  are  carriers  for  the 
SERPINH1 gene T- allele are also at high risk for premature delivery. This T allele 
reduces the promoter activity in amnion fibroblast that deposit fibrillar collagen which 
gives the tensile strength to the amnion (Wang H, Parry S, Macones G et al).
               There is evidence implicating that relaxin is a component of the mechanism of 
membrane rupture. Laboratory experimentation shows that relaxin induces collagenase 
activity when incubated with membranes in vitro (Qin et al).  Also, the relaxin gene is 
over expressed in the membranes of women with PPROM when compared with those 
from women in preterm labour with intact membranes or from women not in labour 
(Bogic et al., 
1997). Other studies have indicated that the relaxin mediated pathway of PPROM is 
independent of infection (Millar et al., 1998).
                                          EVALUATION OF PPROM
          A patient with symptoms suggestive of PPROM should have prompt evaluation. 
Patient history has a sensitivity of 90% for the diagnosis of PPROM (Rodeck et al).
SPECULUM EXAMINATION
           A patient  who  complains  of  leakage  of  fluids  should  have  a  speculum 
examination to evaluate for gross pooling of amniotic fluid in the vagina. If no fluid seen 
on the speculum examination,  the patient  should be instructed to perform a valsalva 
maneuver such as coughing to evaluate if any leakage is visualized from the cervical os. 
Digital examination should be avoided since this increases the risk of infection and little 
information is obtained from this examination (Friedman ML et al).
       Several tests have been utilized to assist in the diagnosis of PPROM if rupture of 
membranes cannot be determined by a Speculum examination alone. The nitrazine paper 
test  and  the  fern  test  may  be  performed.  The  combination  of  the  patient’s  history, 
speculum examination, the nitrazine test, and the fern test for the evaluation of a patient 
with symptoms suggestive of PPROM yields a sensitivity of 93.1 %(Rodeck et al).
w
NITRAZINE TEST
          The normal pH of the vagina during pregnancy is between 4.5 and 5.0. When 
rupture of membranes occurs and the vaginal mucosa is bathed in amniotic fluid whose 
pH is close to 7.3, the pH increases above 6.0, causing the nitrazine paper to turn from 
yellow to blue in colour. However, the nitrazine test may give false positive results if 
contaminated with semen, blood, some lubricants, or if a vaginal infection is present. 
The nitrazine test has 12.7% false negative and 16.2% false positive results.
FERN TEST
            The fern test has been described since  1960s.This test is by placing a swab in the 
posterior fornix of vagina to obtain vaginal fluid and then performing a smear on glass 
slide which should be allowed to dry for 10 minutes. The microscopic appearance of the 
smear as arborisation or fern pattern is a positive test. The reported specificity of fern 
test has been reported to be 84-100% (Bennett SJ et al). The fern test gives 4.8% false 
negative and 4.4%false positive results (Tricomi et al ).
ULTRASOUND  
            Patients with leakage of fluid from vagina may also have a sonographic 
evaluation  of  amniotic  fluid  volume  performed.  It  is  also  important  to  assess  the 
gestational age of the pregnancy, fetal heart rate, and 
the position of fetus. A finding of oligohydromnias may be useful in confirming rupture 
of  fetal  membranes along with the  above tests.  The cervix can also be assessed by 
measuring the dilatation of cervical os, the cervical length, and to determine if funneling 
is present.
FETAL FIBRINONECTIN
            Another  test  that  may  be  useful  to  assess  leakage  of  fluid  is  fetal 
fibrinonectin(FFN). Fetal fibrinonectin is a large molecular weight glycoprotein present 
in large quantities in amniotic fluid. It can be detected in endocervix or the vagina in 
93.8% of women with PROM by means of ELISA. This test can be performed after 18 
weeks of gestation.  A negative test  indicates that  the membranes are intact  since its 
negative predictive value is 98-99%. Nevertheless, it has a poor positive predictive value 
due to its high false positive rate and may not be cost effective. Meconium may interfere 
with results (Lockwood et al).
DYE TEST
             If the diagnosis of rupture of fetal membranes cannot be made with the above 
tests, an ultrasound guided invasive test can be performed. A 22 gauge needle is inserted 
under  ultrasound guidance into amniotic  cavity.  Amniotic  fluid can be obtained and 
evaluated for glucose, white blood cells, 
gram stain, and be sent for culture of amniotic fluid. Indigo carmine or Evans blue (1ml) 
can be instilled. A tampon is placed in the vagina prior to instillation of dye and kept in 
place for 30-60 minutes, when removed,  a blue tinged tampon will be seen if the patient 
has ruptured membranes.
ALPHA FETOPROTEIN
            Alpha fetoprotein (AFP) is present in high concentration in the amniotic fluid but 
does not  exist  in vaginal  secretions or  in the urine.  Therefore,  determination of  this 
substance in the vaginal secretions is an accurate test for diagnoses of PROM. A study 
using a rapid colorimetric monoclonal antibody AFP test found a sensitivity of 98% for 
AFP, 77% for nitrazine, and 62% for ferning. Specificity was 100%  for the AFP test 
(Rochelson  et  al).  The  test  may  be  unreliable  at  term because  amniotic  fluid  AFP 
decreases with gestational age. Also, maternal blood contamination affects the accuracy 
of the test.
AMNISURE
              A new generation test that uses immunochromatographic method(Amnisure) to 
detect  trace  amounts  of  placental  microglobulin  -1(PAMG-1)  has  been  found  to  be 
highly diagnostic with a sensitivity of 99% and specificity of 100%(Cousins LM et al). 
PAMG-1 is a protein produced by the cells of the decidual part of the placenta which 
can be detected in the 
amniotic fluid after the rupture of membranes. The test can be performed using a kit in 
5-10 minutes. 
 NEONATAL COMPLICATIONS OF PPROM
 HYALINE MEMBRANE DISEASE
              HMD (Hyaline Membrane Disease) is the greatest threat to the newborn when 
PROM occurs before term. At 22 weeks, 100% of the newborn will have respiratory 
distress syndrome. At 28 weeks, the incidence of RDS it 85%, at 32 weeks is 25%, and 
at 34 weeks is close to 10%. The National Neonatal Database gives an incidence of RDS 
of 100% at 24 weeks, 97.8% at 27-28 weeks, 58.1% at 31-32 weeks, and 30.9% at 33-34 
weeks. The data are consistent and the differences are probably due to variations in the 
population  being  studied.  From  this,  it  seems  clear  that  expectant  management  to 
improve fetal pulmonary maturity should dominate other consideration before 36 weeks.
INFECTION
               The incidence of sepsis is 36.4%, 24.4%, 1.6%, and 0.8%   at 24 weeks, 27-28 
weeks,  31-32weeks  and  33-34weeks  respectively.  The  infection  is  an  important 
consideration before 28 weeks.  The neonatal  morbidity for  mid-trimester  PPROM is 
35-40%, in the majority of cases this occurs secondary to infection. Infection decreases 
the latency period 
resulting in deliveries at a premature gestational age. Some studies have compared the 
neonatal mortality of those delivered after mid trimester PPROM and controls delivered 
without PPROM having the same gestational age. There was no difference in mortality 
rate  between  the  groups,  indicating  that  the  main  factor  for  neonatal  morbidity  is 
extreme  prematurity  secondary  to  a  decrease  in  latency  period  (Kurkinen-Raty  M, 
Koivisto , Jouppila et al).
PRETERM
              Prematurity is the most significant factor in the increased perinatal mortality 
and morbidity associated with preterm rupture of membranes, because delivery occurs 
within 7 days of PPROM in 80% of cases (Taylor J, Garite TJ et al).  
MUSCULOSKELETAL MORBIDITIES
          Majority of fetal  limb growth occurs  in the second and third trimester  of 
pregnancy.  If  chronic  oligohydramnios  is  present  after  mid-trimester  PPROM,  fetal 
growth and movements are restricted, and the intrauterine pressure becomes asymmetric 
leading to limb position deformities, pulmonary hypoplasia, and craniofacial defects. In 
mid-trimester  PPROM,  the  reported  incidence  for  these  deformities  varies  between 
3.5-50% for cases with severe oligohydramnios (Moretti M, Sibai BM. et al). The risk 
increases when the duration of   PPROM is greater than 14 days ( Killbride HW, Yeast 
JI,  Thibeault DW et al).
INTRA UTERINE FETAL DEMISE
             The incidence of intra-uterine fetal demise after mid trimester PPROM varies, 
but the risk has been reported to be about 9.8%. The rate is proportional to gestational 
age when PROM occurs, decreasing as gestational age increases (Blott M, Greenough et 
al, Major CA, Kitzmiller JL et al).
PULMONARY HYPOPLASIA
               Pulmonary hypoplasia is associated with PPROM occurring prior to 26 weeks 
of gestation. The incidence of pulmonary hypoplasia if PPROM occurs after 26 weeks is 
low (1.4%) (Falk SJ, Campbell LJ, Lee Paritz A et al; Nimrod C, Varela Gittings FI, 
Machin  G et  al).  The  incidence  of  pulmonary  hypoplasia  as  a  complication  of  mid 
trimester PPROM varies depending on the gestational age of pregnancy.  Rotschild et al 
reported an incidence of pulmonary hypoplasia when PPROM occurred at 19 weeks is 
50% and at 25 weeks is 10%. In 1994 Vergani et al described an association between 
severe oligohydramnios and pulmonary hypoplasia. In the study, all the fetuses that had 
pulmonary hypoplasia were born to mothers with a 
median amniotic fluid of less than 2 cm. It is thought that when PPROM occurs, the 
pressure gradient between the amniotic cavity and the alveoli is altered leading to a loss 
of fetal lung fluid to the amniotic cavity, leading to this complication. Oligohydramnios, 
particularly  if  there  is  prolonged PPROM, may  result  in  neonatal  “oligohydramnios 
tetrad” of facial anomalies, limb position defects , pulmonary hypoplasia, and impaired 
fetal growth, all of which add to neonatal morbidity. 
MATERNAL COMPLICATIONS
           The maternal complications most frequently associated   with PPROM are acute 
chorioamnionitis, subclinical chorioamnionitis, premature placental separation and post 
partum endometritis.
ACUTE CHORIOAMNIONITIS
           The diagnosis of chorioamnionitis is clinical. It requires the presence of fever 
(>100F or 37.8°C) and at least two of the following conditions:
             Maternal tachycardia (>100bpm)
             Fetal tachycardia (>160bpm)
             Uterine tenderness
             Foul smelling vaginal discharge
             Maternal leucocytosis(>15000 /cubic mm)
             C-reactive protein >2.7 mg/dl
 
 (Gibbs  et  al,  1982).  Amniocentesis  is  not  necessary  for  the  diagnosis  of  acute 
chorioamnionitis.
            The risk of acute chorioamnionitis is inversely related to gestational age at the 
time of rupture of the membranes. Beydoun and Yasin (1986) found an incidence of 
chorioamnionitis of 58.6% in patients with PROM before 28 weeks. This is in contrast 
with  an  incidence  of  less  than  10% when PROM occurs  after  36  weeks.  The  high 
incidence  of  acute  chorioamnionitis  and  neonatal  infection  when  PROM  occurs  in 
pregnancies  remote  from term may  be  related  to  decreased  antibacterial  activity  of 
amniotic fluid (Schlievert et al, Blanco et al.,). The antibacterial activity of the fluid is 
low in  early  pregnancy  and  increases  with  gestational  age.  Another    factor  is  the 
immaturity   of   the   fetal   immunological   system that limits the ability  of the 
preterm  infants to fight infection.
            Acute chorioamnionitis may be apparent at the time of admission. It may also 
develop during the latency period in women who are not infected during the time of 
admission. In these cases, the incidence of infection is related to the duration of latency 
period. Butchers (1964) found that 1.7% of his patients with PROM developed fever 
within  24  hours,  7.5% between  25-48hours  and  8.6% beyond  48  hours.  Histologic 
chorioamnionitis  is  found  in  10%  of  the  patients  12  hours  after  rupture  of  the 
membranes, in 30% after 24 
hours, in 45% after 48 hours, and in 48% after 72 hours (Naeye and Peters et al.,). Other 
investigators  (Ghidini  et  al.,)  have  found  that  the  incidence  of  histologic 
chorioamnionitis does not increase with the duration of latency period. Internal fetal 
monitoring is another factor that predisposes to chorioamniotic infection. Newton et al 
determined  by  logistic  regression  analysis  that  the  chance  of  developing 
chorioamnionitis  was 20% for  patients who had 20 hours of PROM and 3 hours of 
internal fetal monitoring. This probability increased to 40% if the latency period was 
greater than 20 hours and internal fetal monitoring lasted 12 or more hours. 
SUBCLINICAL CHORlOAMNlONlTlS
         Romero et al demonstrated by means of bacteriologic studies of amniotic fluid that 
approximately 40% of patients with PPROM are infected at the time of admission but 
only a minority of them had signs and symptoms of overt infection. On many occasion, 
the only symptom of chorioamniotic infection is uterine contractions.  Other signs of 
subclinical infections are a change from a reactive to nonreactive pattern in NST and 
absence of respiratory movement in biophysical profile. Desai DR from Belguam, India 
reported that C-reactive protein estimation was superior to urine culture, cervical swab 
culture,  placental  culture,  and histology in detecting subclinical  infection in cases of 
PROM. 
PLACENTAL SEPARATION
         Patients with PROM have an incidence of abruptio placentae of approximately 6% 
which is significantly higher than the 1 in 150 found in patient with intact membranes 
(Vintzileos et al., 1987). Abruption usually occurs within the setting of prolonged and 
severe oligohydramnios. The clinical picture is that of mild to moderate vaginal bleeding 
and preterm labour. Usually abruption is not severe enough to cause fetal demise or 
disseminated intravascular coagulation. The reason for the high incidence of abruption 
in patient with PROM is a progressive decrease in intrauterine surface area, causing 
detachment of placenta. Mukherjee   reported a high incidence of 30% in women with 
preterm labour and PROM suffering from antepartum hemorrhage.
POSTPARTUM ENDOMETRITIS
         Postpartum endometritis is  the most  common maternal complication of mid 
trimester PPROM, particularly if they develop chorioamnionitis and are delivered by 
cesarean section. The incidence has been reported to be between 15-60%. Nevertheless, 
the  incidence  of  postpartum maternal  sepsis  has  been reported  to  be  between 0-3% 
(Shumway JB Al- Malt A, Amon E et al).
(
                                         MANAGEMENT
INITIAL ASSESSMENT
           The main objectives of the initial assessment are to confirm the diagnosis of 
PROM, to determine the gestational age of the fetus, and to identify the women who 
need  to  be  delivered.  Secondary  objectives  will  be  to    determine  fetal  pulmonary 
maturity and to identify subjects colonised with Chlamydia, N.gonorrrhea, and GBS.
            Digital pelvic examination is not a part of assessment of women with PROM 
unless  they  are  in  active  labor  as  defined by the frequency and intensity  of  uterine 
contractions.  It  has  been  demonstrated  that  digital  examination  causes  a  significant 
decrease in the duration of the latency period (Alexander et al).
Gestational age(weeks)
Latency period
Digital examination
No digital examination
24-26
1.6±0.7
1
20.5+19.8
26-28
3.8±5.3
13.9+14.1
28-30
2.1±2.9
14.2+13.3
30-32
1.5±0.8
6.7+6.8
32-34
2.2±5.7
5.5+5.8
34-36
1.2±0.5
5.8+3.6
   Courtesy Lewis DF, Mazor CA, Towers  CV, et al
 
SPECULUM EXAMINATION
           The initial assessment of women with PPROM includes, in addition to the history 
and physical examination, a sterile speculum examination. The speculum examination is 
necessary  to  confirm  the  diagnosis  of  PPROM,  to  obtain  amniotic  fluid  for 
determination of fetal pulmonary maturity and to obtain samples from endocervix. It 
also helps in assessing the dilatation and length of cervix. Before speculum examination 
vaginal swab is taken. Fern test and Nitrazine test are also performed for confirming 
PPROM.
LABORATORY ASSESSMENT  
           The initial laboratory assessment should include a complete blood count, to 
determine the total number of white blood cells, a differential count, and determination 
of C-reactive protein (CRP).
ULTRASOUND EXAMINATION
            Ultrasound examination is done to confirm or determine the fetal position, 
measurement of amniotic fluid volume, fetal biometry for estimation of gestational age 
and fetal weight, and cervical length by trans vaginal ultrasound.
GESTATIONAL AGE DETERMINATION
             The duration of latency period, the management of patient and the fetal and 
neonatal prognosis are heavily dependent on gestational age at the 
time of PROM. Therefore, a precise assessment of gestational age is an important part of 
initial  evaluation  of  women  with  PPROM.  An  ultrasound  examination  in  the  first 
trimester of pregnancy is extremely accurate in estimation of gestational age (Wiser et 
al.,).   Similarly,  an  ultrasound  derived  gestational  age  in  the  second  trimester  of 
pregnancy that does not differ by more than 7 days from the estimate based on last 
menstrual period confirms the diagnosis of gestational age. If the ultrasound derived and 
the  LMP  derived  estimations  of  gestational  age  differ  by  more  than  7  days,  the 
ultrasound  derived  value  is  the  most  accurate  and  should  be  adopted  for  clinical 
management (Chevenak et al.,). It is important to consider that the lack of fluid affects 
the  accuracy  of  ultrasound  measurements  and  the  gestational  age  is  frequently 
underestimated (O’Keefe et al.,).
               After initial assessment, the next step is to identify the women requiring 
immediate delivery. The indication may be maternal or fetal. These indications are
1. women in advanced labor
2. evidence of acute chorioamnionitis
3. evidence of subclinical infection/inflammation
4. women at high risk for severe infection
5. fetuses with mature lung
6.
6
7. fetuses with non reassuring well being test
8. fetuses with lethal abnormalities.
The  management  of  PPROM  is  dictated  by  the  gestational  age  at  the  time  of  its 
occurrence. This is due to variation in the incidence of fetal/neonatal complications at 
different gestational age.
PROM AT 36 WEEKS
         Women with PROM after 36 completed weeks should be delivered. There is little 
gained by conservative management when the pregnancy has advanced to a stage at 
which fetal pulmonary maturity is complete or almost complete and the incidence of 
RDS is minimal. 
PPROM BETWEEN 32 AND 36 WEEKS
          Approximately 50% of the fetuses of women with PPROM between 32 and 36 
weeks of gestation will have adequate lung maturity. The issue of fetal lung maturity is 
important in the management of PPROM between 32 and 36 weeks, a decisive effort is 
made to collect amniotic fluid for lung maturity testing. If the fetal lungs are mature 
active intervention is recommended (Spinnato et al, Mercer et al1993).
          The management of women between 32 and 36 weeks with PPROM is matter of 
discussion among experts.  There are  several  studies favouring induction (Naef et  al, 
Mercer et al1993). Expectant management with 
antibiotics  and steroids decreases the incidence of  RDS, which is  the most  frequent 
neonatal morbidity in this group (Neerhoff et al, Mercer et al 1997).
          The care of these patients should be individualized. Immediate delivery by 
induction may be the best options under certain circumstances like chorioamnionitis, 
oligohydromnios,  non  reassuring  fetal  heart,  active  labour  and  transverse  lie.  The 
women  should  remain  in  hospital  until  delivery.  Antibiotics  should  be  given 
intravenously for 48-72 hours followed by oral treatment for 5-7days. Electronic fetal 
monitoring  should  be  performed  daily.  Patients  should  be  assessed  daily  for  fever, 
maternal or fetal tachycardia, uterine tenderness, and foul smelling discharge. The effect 
of glucocorticoids in preventing RDS in women with PPROM between 32-36 weeks is 
controversial. Similarly incidence of  IVH is rare after 32 weeks. 
PPROM BETWEEN 24 AND 32 WEEKS
            The risks threatening the fetus affected by PPROM between 24 and 32 weeks are 
multiple. The predominant risk is RDS usually due to HMD, affecting 30-100%. Other 
frequent morbidities are sepsis affecting from 10- 50%; IVH affecting between 5 and 
50%;  necrotizing  enterocolitis  affecting  1-10%;  and  chronic  lung  disease  affecting 
between 2 and 80%. All of these complications are directly related to gestational age at 
the time of  birth and are more frequent and severe when pregnancy is less  than 28 
weeks.
w
            The obstetrical management of women with PPROM between 24 and 32 weeks 
should be directed towards prolongation of the latency period, prevention of RDS and 
IVH,  and  prevention  of  fetal/neonatal  and  maternal  infectious  morbidity.  These  are 
achieved  through  the  use  of  antibiotics,  steroids  and  tocolytic  agents.  Women  with 
PPROM between 24 and 32 weeks should be admitted to the hospital and remain as 
inpatients until delivery. They should be on bed rest with bathroom privileges.
PPROM BEFORE 24 WEEKS 
            The perinatal outcome of PPROM before 24 weeks of gestation is poor. 48% of 
these patients will deliver within 3 days, 67% within 1week, and 83% within 2 weeks of 
PPROM (Moretti and sibai et al). Perinatal mortality is 60-90%. Approximately 50% of 
mothers will have choriooamnionitis, 50% will be delivered by cesarean section, and 
6.8% will have abruption. 16% of the surviving newborn has severe long term sequelae. 
Most of the survivors are patients who extend their latent period for 2 or more weeks. 
Some  patients  have  pregnancy  prolonged  for  several  weeks  after  PPROM  without 
evidence  of  infection  with  little  or  no  liquor  amnii.  They  are  at  high  risk  for 
musculoskeletal deformities and pulmonary hypoplasia. Deformities usually appear after 
4 or more weeks of PPROM.
             If the pregnancy is less than 24 weeks the mother should be offered induction of labour and 
delivery of the fetus to avoid morbidity. If the patient chooses termination it should be made clear that 
there is 10-20% probability that the fetus will be born alive. If the mother declines termination and 
chooses expectant management, she will be treated with tocolytics,  glucocorticoids, and antibiotics. If 
the patient is less than 24 weeks she may be sent home and readmitted in hospital for further expectant 
management after she completes 24 weeks.                                   
TOCOLYTICS IN PPROM
                PPROM is a major cause of preterm deliveries and perinatal morbidity; hence 
the use of tocolysis may be appealing to the obstetrician. However, tocolytic use in case 
of  PPROM is  controversial.  Several  randomized  controlled  studies  have  been  done 
looking at oral tocolytics in PPROM, intravenous tocolytics, and short term and long 
term  tocolysis(Mastuda  Y  et  al,  Levy  DL  et  al).  All  these  studies  failed  to  show 
decreased perinatal  morbidity or improvement in neonatal  outcome. Also, the use of 
tocolytics  may  be  of  concern  since  the  incidence  of  perinatal  infection  is  high  and 
prolongation of these pregnancies is not desired. However, they may be useful in women 
with contractions at the time of admission who may deliver before receiving the benefit 
of glucocorticoid 
administration. Aggressive tocolysis after PPROM does not prolong the pregnancy or 
reduce neonatal mortality more than a limited treatment for a few days (Combs et al).
 ROLE OF ANTENATAL CORTICOSTEROIDS
              The use of antenatal corticosteroids is controversial in a pregnancy complicated 
by PPROM. Prospective, randomized, control studies have not shown a decrease in rate 
or severity of RDS in patients receiving antenatal corticosteroids (Morales wet al, Block 
MF et al.). These studies also showed a small increase in postpartum endometritis and 
neonatal infections. 
              In 1994, the National institute of Health consensus conference recommended 
the use of antenatal corticosteroids for those patients who were ≤32 weeks of gestation. 
This  recommendation  was  made because  there  was  a  decrease  in  IVH and cerebral 
palsy. Since 1998, the American college of Obstetricians and Gynaecologist  (ACOG) 
recommends the use of corticosteroids to gravidas with PPROM before 32 weeks of 
gestation without the evidence of chorioamnionitis to decrease the incidence of RDS 
IVH, NEC and neonatal death (ACOG Practice Bulletin ). This decision was prompted 
by a study by Lewis et al,  where 18% (corticosteroid treated) to 44% (untreated) of 
infants had respiratory distress with no obvious increased risk for infection (5% to 3%). 
Although corticosteroid may potentially 
increase the risk of  perinatal  infection,  they should be administered to patients  with 
PPROM of less than 32 weeks of gestation, since the neonatal benefits may outweigh 
the risk.
ANTIBIOTIC PROPHYLAXIS
                 The purpose of prophylactic antibiotics for patients with PPROM is to 
decrease  the  risk  of  perinatal  infections  and  to  increase  the  latency  period.  A  few 
randomized control studies have shown a prolongation of the latency period of 5-7 days, 
and a decrease in the incidence of postpartum endometritis and neonatal sepsis (Amon et 
al, Lovett et al). Prolongation of the latency period is important because FLM improves 
with advancing gestational age, resulting in fewer days in the ventilator and shorter stay 
in the NICU. It has been calculated that every day that the preterm fetus remains inside 
of the uterus is equivalent to 2-3 days less that the neonate will stay in NICU.
               Incidence of severe IVH, neonatal sepsis,  pneumonia, and necrotizing 
enterocolitis are reduced with the use of ampicillin or erythromycin (NIH Maternal Fetal 
Collaborative Group and the Oracle I Randomised Trial). No effect of antibiotics has 
been demonstrated with respect to respiratory distress syndrome. Several antibiotics are 
used in these trials, including ampicillin IV plus amoxillin orally for 7 days. Cephalexin 
IV until delivery, Piperacillin IV for 72 hours, ampicillin/gentamycin/clindamycin IV 
for  24 hrs  plus  ampicillin/clavulanate  orally  for  7  days,  ampicillin/sulbactam IV for 
48hrs plus ampicillin/clavulanate orally for 5-7 days, ampicillin/erythromycin IV for 48 
hrs  plus  amoxycillin/erythromycin  orally  until  delivery.  Administration  of 
ampicillin/sulbactam  has  been  associated  with  higher  incidence  of  necrotizing 
enterocolitis(Kenyon et al).
                There is no evidence to recommend a particular duration of antibiotic therapy. 
It is important that antibiotics are effective against GBS and E.coli.  Azithromycin is 
added if chlamydia is present in culture and Rocephin if N.gonorrhoea is present.  A 
commonly  used  regimen  is  cefazolin  2  g  IV  every  8  hrs  for  48  hrs  followed  by 
cephalexin 250 mg orally for 5 days. Recent evidence suggested the results are similar 
with or without oral therapy (Segel et al, Svena et al). 
SURGICAL APPROACHES TO THE TREATMENT OF PPROM
              The site of rupture can be visualized endoscopically (Quintero et al 1998). The 
site is usually located above the internal cervical os in case of spontaneous rupture while 
in traumatic rupture, following amniocentesis, or fetal surgery, the site is far from the 
cervix. Shortly after rupture, the slit in 
the membranes has clean, sharp edges that become irregular with the passage of time.
              Various experimental approaches have been used to seal the site of rupture. The 
first attempts were made using fibrin glue from mixing thrombin with cryoprecipitate, 
and  then  came  AMNIOPATCH  created  by  successive  intra-amniotic  injections  of 
platelets  and  cryoprecipitate  (Quintero  et  al  1999).  This  method  is  not  useful  in 
spontaneous rupture. Also sudden fetal death may occur in some cases most probably 
because  of  release  of  substances  toxic  to  the  fetus  by  the  activated  platelets. 
Transcervical application of commercial fibrin tissue sealant made up of cryoprecipitate 
and thrombin has been tried (Sciscione et al). Another potential surgical treatment for 
PROM is use of gelatin sponge embolisation(O’Brien et al).
SPECIAL SITUATIONS IN WOMEN WITH PPROM
PPROM WITH CERVICAL CERCLAGE IN SITU  
           PPROM occurs in 30-50% of cases of rescue cerclage and in about 5-10% of 
cases of prophylactic cerclage. When PPROM occurs in pregnancies at >34 weeks, there 
are  no  substantial  advantages  of  prolongation  of  pregnancy  and  cerclage  should  be 
removed and labour induced if there is no spontaneous labour within 24-48 hours. In 
most of these cases cerclage 
removal  is  followed by spontaneous  labour  and delivery.  The  management  problem 
occurs when PPROM occurs far from term in a woman with cerclage “in situ’’ because 
the literature in the era before antibiotic treatment for PPROM strongly suggested that 
incidence of infection was greater when the cerclage remained “in situ” than when it was 
removed(Ludmir  et  al).The  contemporary  treatment  with  antibiotics  of  women  with 
PROM has modified the outcome of these patients,  and most of the recent literature 
suggests that cerclage should not be removed (Jenkins at al., ,McElrath et al.). If the 
cerclage is left “in situ” and the mother is treated with antibiotics, the latency period will 
be prolonged without significant increases in fetal/  neonatal morbidity and mortality. 
Exceptions will be cases with overt choriamnionitis , active labour, or non reassuring 
fetal status.
PPROM IN MULTlFETAL PREGNANCIES
          PPROM occurs more frequently in twin than singleton gestations (7.4% versus 
3.7%) (Mecer et al).  The reported mean gestational  age at which PPROM occurs in 
multifetal  gestations  is  30  weeks.  When  compared  to  a  singleton  pregnancy  with 
PPROM matched for gestational age, the event occurring in multifetal pregnancies has a 
shorter latency period (Bianco AT et al., Jacquemyn Y et al).
s
        When PPROM occurs in a twin pregnancy, the ruptured sac can be from presenting 
fetus, from the sac of the non presenting fetus, or from the interamnionic membrane. 
When PPROM occurs from the sac of the presenting fetus, the non presenting fetus has 
an increased incidence of RDS as well  as prolonged oxygen therapy. There are few 
cases reported on the management of PPROM when occurring from the nonpresenting 
twin.
            If PPROM occurs early in the second trimester, termination of the pregnancy 
should be offered, since the risk of continuing the pregnancy outweighs the benefit of 
expectant management. Delayed interval delivery of the presenting twin after PPROM 
may be an option in selected cases. Contraindications to offer this option to a patient are 
suspected placental abruption, intra-amnion infection, and non reassuring fetal status. A 
monochorionic  placenta  is  a  relative  contraindication.  The  management  of  delayed 
interval delivery is ligation of umbilical cord with an absorbable suture after vaginal 
delivery,  followed  by  tocolytics  and  antimicrobials.  The  placement  of  cerclage  is 
controversial.
HERPES GENITALIS AND PPROM
           If  a  mother  has  PPROM with active  genital  lesions,  chance  of  perinatal 
transmission  is  present.  It  is  necessary  to  balance  the  benefits  of  prolongation  of 
pregnancy against the possibility of ascending fetal 
infection. Delivery by cesarean is the best mode if pregnancy is beyond 34 weeks. In 
pregnancy  less  than  34  weeks  ,  there  is  limited  evidence  indicating  that  expectant 
management is  adequate,  and fetus do not become infected with HSV if the latency 
period is prolonged (Major et al.).
HIV AND PPROM
             A major risk factor for vertical transmission of HlV is the duration of ruptured 
membranes prior to delivery. There is a significant increase in vertical transmission rate 
if duration of rupture of membranes was greater than 4 hrs in patient with low CD4 
levels.  (Minkoff  et  al).   Other  studies  confirmed that  among HIV infected pregnant 
women, ruptured membranes greater than 4 hrs prior to delivery significantly increased 
the rate of vertical transmission from 25% as compared to 14% among mothers with a 
shorter length of ruptured membranes (Landesman SH et al.,).
AIM OF THE STUDY
AAIM
 To compare active versus expectant management in women with preterm 
premature rupture of membranes between 34 and 37 weeks.
 To compare the maternal morbidity in active versus expectant management.
 To critically evaluate the neonatal outcome in both mode of management
MATERIALS AND 
METHODS
MATERIALS AND METHODS
     The  prospective  study  was  carried  out  in  the  Department  of  Obstetrics  and 
Gynaecology  Government  RSRM  Lying-in  Hospital  attached  to  Stanley  Medical 
College,  Chennai  during  the  period  of  one  year  from  October  2008  to  September 
2009.154 cases satisfying the criteria were clinically evaluated and followed up.
             The study group consists of pregnant women with preterm premature rupture of 
membranes with gestational age between 34 weeks 0 days to 36 weeks 6 days.
INCLUSION CRITERIA
              Pregnant women between 34 to 37 weeks of gestation with
a. PPROM
b. Singleton  with vertex or breech presentation
c. Multiple pregnancy with 1st twin in vertex presentation
d. Previous  LSCS
EXCLUSION CRITERIA
a. Twin pregnancy with non vertex presentation.
b. Major congenital anomalies
c. Non reassuring fetal heart rate in CTG.
d. Active labour.
e.
e
f. Meconium stained amniotic fluid
g. HELLP syndrome or severe pre ecclampsia.
h. Signs of infection in mother and fetus
i. Severe oligohydromnios
j. Other obstetrics and medical complications
              All patients between 34 and 37 weeks who reported with a history of PPROM, 
was confirmed by sterile speculum examination/nitrazine test/fern test.
            The  gestational  age was  ascertained by LMP and first  trimester  dating 
ultrasound. If the disparity between LMP and USG based gestational age was more than 
7 days then gestational age was assumed as per USG. 
           The pregnant women were admitted and all baseline investigations like Hb, urine 
albumin and sugar, blood sugar, blood grouping and typing, HIV and VDRL were done. 
High vaginal swab was taken for culture and sensitivity.
            Maternal temperature, pulse, blood pressure and fetal heart rate were recorded. 
Non stress test was done.
            A sterile pelvic examination was done to assess the initial bishop score. Further 
digital examinations were prohibited.   
EXPECTANT MANAGEMENT
E
           Patient who were managed expectantly were observed in labour room for the 
initial period with continuous external fetal heart rate monitoring and tocodynamometry. 
In  the  absence  of  non  reassuring  fetal  status,  initiation  of  labour  and  absence  of 
infection,  these patients  were transferred to  an antepartum room where the maternal 
vitals and FHR were monitored periodically. 
          The women were advised bed rest. In our hospital IV ampicillin 2 gms every 8 hrs 
for 48hrs given followed by oral amoxycillin for 7 days or until patient goes into labour.
           Daily modified biophysical profile was carried out. Delivery was either by 
spontaneous onset of labour or when termination is indicated by the non reassuring fetal 
heart rate, or signs of chorioamnionitis, or with the development of oligohydramnios.
            Cesarean delivery is indicated for obstetric indications. Acceleration of labour 
was done by oxytocin. 
ACTIVE MANAGEMENT
            In patients managed actively, labour was induced by either oxytocin continuous 
infusion or  intracervical  instillation of  PgE2 gel.  Cesarean section was indicated for 
obstetric indication. 
o
        Oxytocin was administered by continuous infusion starting with 5mu/min and 
doubling the dose until a satisfactory labour pattern is established. 
         0.5 mg of PgE2 gel is instilled intracervically and assessment of bishop’s score 
was done after 6 hrs followed by oxytocin acceleration.In either case labour is monitored 
carefully using a partogram. Cesarean was indicated for obstetric reasons.
           Clinical chorioamnionitis was defined, by a temperature of >100.4F with uterine 
tenderness,  leucocytosis,  maternal  or  fetal  tachycardia,  or  a  foul  smelling  vaginal 
discharge.  All  patients  with  chorioamnionitis  received  intravenous  ampicillin  and 
gentamycin, regardless of group assignment ,and the antibiotic therapy was continued 
until the patient was afebrile for 48 hours post partum.
         
              The infants are managed by pediatrician. Intrapartum maternal hyperpyrexia or 
clinical findings suggestive of neonatal infection resulted in admission to the neonatal 
intensive care unit for  sepsis evaluation. The diagnosis of neonatal sepsis was made in 
infants  with  positive  blood  cultures.  However,  all  the  babies  with  suspected  sepsis 
received empirical broad spectrum antibiotics until culture results were negative.
r
         RDS was defined as early onset of tachypnea, retractions, and oxygen requirement 
for 24hrs, or mechanical ventilation with radiographic confirmation.   
         The mother was followed post partum, any signs of post partum endometritis like 
fever greater than 100.4 F with uterine tenderness were watched for, until discharge. 
OBSERVATION AND
ANALYSIS
              OBSERVATION AND ANALYSIS
               During the study period, out of the 154 patients 88 were managed actively and 
66  were  managed  expectantly.  The  statistical  analysis  of  group  differences  was 
accomplished with the use of Chi squire test and Fisher’s exact test as appropriate for 
discrete  data  and the student  t  test  for  continuous data.  Significant  differences were 
accepted at p≤0.05. The observed data are tabulated as follows 
Table 1: Distribution of age in both categories
Age in yrs
Active Expectant
No Percentage No Percentage
15 - 20 8 9.09% 10 15.15%
21 - 25 56 63.64% 32 48.48%
25 - 30 24 27.27% 18 27.27%
         >30      -          -      6          9.09%
          In this study, in active  management group 63.64% of women belonged to 21-25 
yrs of age, 27.27% belonging to 25-30 yrs of age and 9.09% to 15-20 yrs of age. In 
expectant management group, 48.48% were in 21-25yrs of age, 27.27%in 25-30yrs of 
age, 15% in 15-20yrs of age, and 9.09% in greater than 30 years of age. 
a
Distribution of maternal age in both categories
Table 2: Distribution of gravidity in both groups
Obs Code
Active Expectant
No Percentage No Percentage
PRIMI 50 56.82% 36 54.55%
G2 28 31.82% 20 30.30%
G3 10 11.36% 10 15.15%
      In this study, in both the groups around 55% were primi, 30% were second gravida, 
and 12% were third gravida. Incidentally gravidity distribution is similar in both the 
groups.
Distribution of gravidity in both groups 
pTable 3: Gestational age at PPROM 
GA in 
weeks
Active Expectant 
No Percentage No Percentage
34 14 15.91% 26 39.39%
35 20 22.73% 20 30.30%
36 54 61.36% 20 30.30%
 
        In this study in active management group 61.36% belonged to 36 weeks of 
gestation, 22.73% to 35 weeks, and 15.91% to 34 weeks of gestation. In expectant group 
39.39% belong to 34 weeks of gestation, 30.30% to 35 and 36 weeks of gestation each.
3
Distribution of Gestational age at PPROM in both groups
Table 4: Duration of PPROM at the time of admission
Draining 
Since
Active Expectant 
No Percentage No Percentage
<6 23 26.14% 31 46.97%
6-12 33 37.50% 17 25.76%
12-24 26 29.55% 16 24.24%
24-48 6 6.82% 2 3.03%
 
         When we look at the distribution of the duration of draining at the time of 
admission in both the groups, in active management group 26.14% had draining of less 
than 6 hrs,37.50% within 6-12hrs,29.55% within 12-24hrs, 6.82% within 24-48hrs. In 
expectant  management group 46.97% had draining of  less  than 6 hrs,25.76% within 
6-12hrs,24.42%  within  12-24  hrs,  and  3.03%within  24-48hrs.In  this  study,  in  both 
groups   95% of the patients were admitted within 24 hrs of draining.  
Duration of PPROM at the time of admission
Table 5: Mode of induction of labour in active management group
Mode of 
Onset
Active
No Percentage
PGE2 4 5.79%
Oxytocin 65 94.20%
     Out of the 88 patients in active group  63 received oxytocin for induction, 4 were 
induced with PgE2 gel since bishop’s score was less than 4.   
Mode of induction of labour-Active group
Table 6: Mode of delivery
Mode of 
Delivery
Active Expectant 
No Percentage No Percentage
C/S 32 36.36% 10 15.15%
LN 56 63.64% 52 78.79%
Outlet 0 0.00% 4 6.06%
     In this study, of the 88 patients managed actively 32(36.36%) patients had cesarean 
section,  and  56(63.64%)  had  labour  natural.  In  expectantly  managed  patients 
10(15.15%) had cesarean section,  52(78.79%) had labour  natural,  and 4(6.06%) had 
outlet forceps delivery.
Mode of delivery
          
Table 7: Comparison of cesarean section in both groups
Mode of 
Managemen
t
 No of 
cesarean Percentage 
Total no 
of 
patients 
A 32 76.19% 88
E 10 23.81% 66
Total 42 100% 154
P =0.0034
The P value is significant indicating cesarean rate is increased in active group. Out of 
total cesarean in this study, 76.19% was done in active management group. This increase 
was because of inclusion of previous LSCS and breech with PPROM.
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Table 8: Indications for cesarean
If C/S Ind
Active Expectant
No Percentage No Percentage
Breech 3 9.38% 2 20.00%
FTP 11 34.37% 0 0.00%
MSAF 0 0.00% 4 40.00%
Oligo 0 0.00% 3 30.00%
PreviousLSC
S 16 50.00% 0 0.00%
Others 2 6.25% 1 10.00%
        
In active management group 50% of LSCS is done for previous LSCS with PPROM, 
34.37%  for  failure  to  progress,  9.38%  for  breech,  and  6.25%  for  other  causes.  In 
expectant  management  group  40%  of  LSCS  was  done  for  MSAF,  30%  for 
oligohydromnios, 20% for breech and 10% for other causes. Barring previous LSCS as 
an indication, the rate of cesarean section in active group was 18.18% as against 15.15% 
in expectant management group. In this study, in active group the cesarean section rate 
is influenced by inclusion of previous LSCS.  
Table 9: Comparison  mean of Admission delivery interval in both groups
Variable
Mode of 
Management N Mean Std Dev Minimum Maximum
AD_interval A
8
8
5.386
4 3.015 1 14
AD_interval E
6
6
22.27
3 18.311 4 88
AD_interval Diff (1-2) -16.89 12.19
P<0.001
        The mean admission delivery interval in active management group is 5.38hrs and in 
expectant group it is 22.27hrs.  By applying equality of variances P<0.001 indicates a 
significant  difference  in  admission  delivery  interval  in  between  the  groups.  It  was 
prolonged by an average of 16.89 hrs in the expectant management group. The short 
admission delivery interval in active management group was because of early induction 
of labour.
Table 10: Duration of onset of PPROM to delivery in both groups.
Interval between 
PPROM and 
delivery in hrs
Active Expectant 
No Percentage No Percentage
< 24 70 79.55% 25 37.88%
24 - 48 18 20.45% 31 46.97%
> 48 0 0.00% 10 15.15%
              In this study in active management group,70 (79.55%) delivered within 24 hrs, 
18 (20.45%) within 24-28hrs. Of the 18 delivered after 24 hrs, 15 patients were admitted 
after 24 hrs of PPROM. In expectant management group 24(37.88%) delivered within 
24hrs, 31(46.97%) within 24-48 hrs, 10(15.15%) delivered after 48hrs. The increase in 
the duration of interval between PPROM and delivery in expectant group was due to 
prolongation of latent period. 
Duration of onset of  PPROM to delivery in both groups
Table 11: Relationship between GA, latent period and admission delivery interval 
in expectant group 
Gestational age in 
weeks
Mean  Latent period   in 
hrs 
Mean admission delivery 
interval in hrs
34 34.27 24.19
35 22.3 19.2
36 26.75 24.05
        The mean latent period and admission delivery interval was 34.27hrs and 24.19hrs, 
22.3hrs  and  19.2hrs,  26.75hrs  and  24.05hrs  at  34weeks,  35weeks,  and  36weeks 
respectively.  There  was  a  positive  correlation  between  latent  period  and  admission 
delivery interval. And also lesser the gestational age longer the latent period.
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Table 12: Comparison of duration of hospital stay in mother 
Days 
of 
hospit
al stay
Active   Expectant Diff in 
mean
Diff in 
std dev
P value
No  Mean Std 
dev
No Mean Std 
dev
C/S 32 8.22 0.18 10 9.4 0.27 -1.18 -0.09 <0.001
LN 56 3.41 0.46 52 4.15 0.68 -0.74 -0.22 <0.001
      The mean duration of hospital stay of mother in cesarean section        was 8.22days and 9.4days, in 
labour natural was 3.41days and 4.15days in active and conservative management respectively. 
P<0.001 implies significant prolongation of hospital stay in expectant group. This was due to the 
prolonged admission delivery interval in expectant group.  
Table 13: Comparison of mean of birth weight between groups
Variable
Mode_of_ 
Managemen
t N Mean
Std De
v
Minimu
m
Maximu
m
Baby_W
t A 88 2.496 0.353 1.75 3.2
Baby_W
t E 66 2.307 0.2815 1.8 3
Baby_W
t Diff (1-2)  0.189 0.3244   
     P=0.056
         The average birth weight of infant in active mode of management was 2.496 kg 
with a standard deviation of 0.353kg. In case of expectant management the average birth 
weight  was 2.307kg with a  standard deviation of  0.281kg.  There was no significant 
difference in birth weight of infants born of both mode of management.
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Table 14: Distribution of baby weight
Mode of 
Management
Baby Weight in kg
Total<2 2-2.5 > 2.5 
A 6 42 40 88
E 9 46 12 67
Total 15 88 52 155
           In this study, out of 88 babies born in active management 6(6.82%) weighed less than 2 kg, 
42(47.73%) weighed between 2-2.5kg, and 40(45.45%) weighed greater than 2.5kg. In the expectant 
management group out of 67 babies born, 9(18.42%) weighed less than 2kg, 46(68.66%) weighed 
between 2-2.5kg, and 12(17.91%) weighed greater than 2.5kg.
bDistribution of baby weight in both groups
DTable15: Comparison of Apgar score in both groups
Active   (no=88) Expectant (no=67) Diff in 
mean
Diff in 
std dev
P value
Mean Std dev Mean Std dev
Apgar 1’ 5.602 1.483 5.298 1.061 0.304 0.422 0.095
Apgar 5’ 7.568 0.478 7.477 0.556 0.091 -0.078 0.440
         The mean Apgar score at 1 minute was 5.6 and 5.29, at 5 minute was 7.56 and 7.47 
in active and expectant management respectively. There was no statistically significant 
difference in the Apgar score in both mode of management.
d
Table 16: NICU admission
Infant admitted in NICU Infants not admitted
No Percentage No Percentage 
Active 33 37.50% 55 62.50%
Expectant 23 34.32% 44 65.67%
P=0.684
         In this study, in active group 37.50% of infants were admitted in NICU and in 
expectant group 34.32% of infants were admitted in NICU. There was a small decrease 
in NICU admission in expectant management group which was not statistically 
significant (P=0.684). 
s
Table17: Causes for NICU admission
NICU Active Expectant P value
Admission No Percentage No Percentage
Preterm 10 30.30% 5 21.73%
0.416
LBW 4 12.12% 4 17.39%
0.259
BirthAsphyxi
a 4 12.12% 2 8.69%
0.488
RDS 11 33.33% 4 17.39%
0.140
Sepsis 2 6.06% 6 26.08%
0.067
Others 10 30.30% 5 21.73%
0.416
     In this study in the active group out of 33cases admitted in NICU 11(33.33%) for RDS, 10(30.30%) 
for preterm and borderline term,4 (12.12%) each for LBW and birth asphyxia, and 2(6.06%) for sepsis. 
In this group 4 preterm, 2 borderline term, 1 LBW neonate had RDS. In the expectant  management 
group, out of 23 patients admitted 5(21.73%) for preterm, 6(26.08%) for sepsis, 4(17.39%) each for 
LBW and RDS, 2(8.69%) for birth asphyxia, and 5(21.73%) for other reasons like MSAF and jaundice. 
Incidence of preterm and RDS was high in the active management group. Incidence of sepsis was high 
in expectant group. These values are not statistically significant as seen from P values. Of the 15 
diagnosed with RDS 8 were of 34 weeks of GA, 4 were of 35weeks of GA, and 3 of 36 weeks of GA. 
This implies that RDS was more common in lower gestational age. Of the 8 diagnosed sepsis, 5 had 
admission delivery interval 
greater than 24 hrs. This implies the significance of latent period and admission delivery interval over 
the incidence of sepsis. 
CAUSES FOR NICU ADMISSION 
Table 18: Comparison of days of hospitalization in newborn
Variable
Mode_of_ 
Management N Mean
Std De
v
Minimu
m
Maximu
m
DOH 
newbor
n A 88 2.903 0.623 2 5
DOH 
newbor
n E 67 2.782 0.905 1 6
DOH 
newbor
n Diff (1-2)  0.121 -0.282   
P=0.623
               The average stay of newborn in NICU was 2.90 and 2.78 in active and expectant mode of 
management. P=0.623 signifies there was no statistically significant difference in hospital stay in 
between active and expectant mode of management.
DISCUSSION
                                    DISCUSSION
            There was no difference in gravidity distribution in both groups.  More than 95% 
of the women in both groups were admitted to the hospital within 24 hrs of membrane 
rupture.
               Labour ensues within few hours in most cases. Nearly 50% of patients with PPROM go into 
labour within first 24 hours and 90% within 1 week (Garite et al,Johnson et al,). In present study in 
expectant group, of the 66 patients, 25(37.88%) delivered within 24 hours, all patients delivered within 
4 days. In the work of Neerhof et al only 10% of the women managed expectantly had latency period 
greater than 48 hours. In present study in expectant management group 12.12% had latency period 
more than 48 hrs.  In actively managed group, of the 88, 70(79.55%) delivered within 24 hours and all 
the remaining within next 24 hour. 
            
             The rate of cesarean section was increased in women managed actively it 
contributed to 36.36% deliveries in active group against the 15.15% in expectant group. 
The  higher  rate  of  cesarean  section  in  active  group  was  attributed  to  inclusion  of 
previous LSCS. Barring the cases of previous LSCS, the rate of cesarean section was 
18.18% in active group and 15.15% in conservative group. The incidence of cesarean 
section was similar in both groups in the study by Naef et al.
s
           There were 4 forceps delivery in expectant group as against none in active group.
          There was 3 reported chorioamnionitis in expectant management as against none 
in  active  group.  Incidence  is  4.5%.  In  the  study  by  Naef  et  al  incidence  of 
chorioamnionitis is 16% in expectant and 2% in active group. The decreased incidence 
of chorioamnionitis was due to the prophylactic use of antibiotics and nearly 85% of 
cases delivered within 48 hours in both the groups.
            In our study we find prolonged hospital stay in mothers  managed expectantly. It 
was 9.4 days for cesarean and 4.15 days for labour natural in expectant as against 8.22 
days  and  3.41  days  in  active  management.   Mercer  et  al  reported  prolonged 
hospitalization of mothers in women managed expectantly between 32 and 36 weeks.
            There were no incidence of placental abruption and puerperal sepsis in both 
groups.
            There was no difference between mean birth weight of babies in both mode of 
management. It was 2.49 kg in active and 2.3 in expectant group. Mean apgar score at 1’ 
and  5’  were  5.6  and  7.56,  and  5.29  and  7.47  in  active  and  expectant  management 
respectively. There was no significant difference 
in apgar score. The study by Naef et al also showed that Apgar scores at 1 and 5 minutes 
are identical in both modes of management.
            A comparison between neonatal morbidity between Naef et al and the present 
study is given below
Respiratory distress sepsis
Studies Active Expectant Active Expectant 
Naef et al 5% 5% 0% 5%
Present 12.5% 5.97% 3.40% 9.09%
              The RDS was slightly higher in active group. In patient managed expectantly the incidence 
decreases. The incidence of sepsis was increased in expectant group and this in turn was dependant on 
the latent period, but this difference was not statistically significant. Mercer et al also reported higher 
incidence of infectious morbidity in neonates of expectant management group.
            The incidence of RDS between 33 and 36 weeks in the national neonatal database was 30%. In 
a study by Lewis et al  of preterm premature rupture of membranes reported 14.9% incidence of RDS 
at 34 weeks. It was decreased in 35 and 36 weeks. In present study it was 20% in 34 weeks,10% in 35 
weeks and 4% in 36 weeks of gestation.
                 The rate of NICU admission was 37.50% in active group as against 34.32% in 
the expectant group. The duration of hospital stay was 
similar in both groups. Naef et al, in his study said there is no significant difference in 
hospital stay in both groups. Liemann et al in his study on preterm premature rupture of 
membranes reported no significant improvement in major and minor neonatal morbidity 
in fetuses delivered after 34 weeks of gestation managed expectantly.
              There was no still birth or neonatal death in both groups in present study.
SUMMARY
                                   SUMMARY  
  During the one year period of study,154 cases were studied , with 88 in active group 
and 66 in expectant management.
      Admission delivery interval was reduced in active management group and it was 
prolonged in expectant management group.
      Admission delivery interval in turn is dependent on gestational age and latent period 
in expectant group.
      The rate of cesarean section ( 36.36%)is higher in active management group. But 
this was influenced by the inclusion of previous LSCS.
      There  was  increased incidence of  chorioamnionitis  (4.54%) as opposed to  nil 
incidence in active management group.
      Maternal hospital stay was prolonged in expectant  management group
      There was no difference in mean birth weight of babies in both groups.
      There was no significant difference in 1 minute and 5 minute apgar score between 
active and expectant management.
      There was a slightly higher incidence of RDS and preterm in the active management 
group.
      Incidence of neonatal sepsis was higher in expectant management group.
      There was no statistically significant difference  in hospital stay in neonates in both 
modes of management.
CONCLUSION
C                                 CONCLUSION
       
        From this study it is concluded that, active line of management in patients with 
preterm premature rupture of membranes at 34 weeks 0 days to 36 weeks 6 days of 
gestation  is  associated  with  less  chorioamnionitis,  and  less  neonatal  infectious 
morbidities. 
     In the expectant group, the admission delivery interval is prolonged with increase in 
the  incidence  of  chorioamnionitis,  and neonatal  sepsis  with prolonged hospital  stay. 
There was slight reduction in RDS, since few days in utero are gained. Overall there is 
no added benefit in managing patients with PPROM between 34 weeks 0 days to 36 
weeks 6 days expectantly.
      Hence patients with preterm premature rupture of membranes at 34 to 37 weeks 
gestation can be considered as candidates for active line of management.
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   PROFORMA
Name:
Age;
Ip no:
Educational status:
Income: occupation:
DoA:
LMP:
EDD: 
Scan EDD:
Ht:
Wt:
BMI:
Admitted for
Men h/o:
Mar h/o:
Obs h/o:
Past h/o:
Examination:
E
Temp:
Pulse:
BP:
CVS: 
RS:
Abdomen
Speculam:
Nitrazine paper test:
Fern test;
Vaginal:
Hb: 
Total count:
Differential count:
ESR:
Urine alb/sugar:
Bd g/t:
HIV :
VDRL:
High vaginal  swab:
H
USG:
CTG:
Drugs:
Mode of management:
Time of onset of labour:
Mode of onset:
Mode of delivery:
Signs of chorioamnionitis;
If c/s ind:
Baby weight: 
Apgar score:
NICU admission  if any ind: 
Post op/post natal  period:     
DoD:     
 
                         
 
                              
  ABBREVIATIONS
AFP – Alpha Feto Protein
C/S – Cesarean Section
CRP- C Reactive Protein
FHR – Fetal Heart Rate
FLM 
 Fetal Lung Maturity
FTP – Failure To Progress
GA –Gestational Age
GBS – Group B Streptococcus
HIV – Human Immynodeficiency Virus
HMD – Hyaline Membrane Disease
HSV- Herpes Simplex Virus
IVH –
 Intra Ventricular Hemorrhage
LBW – Low Birth Weight 
LMP-Last Menstrual PERIOD
LN – Labour Natural
LSCS – Lower Segment Cesarean Section
MMPs- Matrix MetalloProteinases
MSAF – Meconium Stained Amniotic Fluid
NEC 
 Necrotising Entero Colitis
NICU- Neonatal Intensive Care Unit
PPROM - Preterm Premature Rupture  of Membranes
PROM- Preterm rupture of membranes
RDS – Respiratory Distress Syndrome
USG – UltraSonoGram
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